| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 4. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | mesalazine (Salofalk®) |
| Formulation | 3 g prolonged-release granules |
| Reference number | 1972 |
| Indication | Treatment of acute episodes and the maintenance of remission of ulcerative colitis |
| Company | Dr Falk Pharma UK Ltd |
| BNF chapter | Gastro-intestinal system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 21/02/2013 |